Acute Urodynamic Effects of Percutaneous Posterior Tibial Nerve Stimulation on Neurogenic Detrusor Overactivity in Patients With Parkinson's Disease

被引:68
|
作者
Kabay, Sibel Canbaz [1 ]
Kabay, Sahin [1 ]
Yucel, Mehmet [1 ]
Ozden, Hilmi [1 ]
机构
[1] Dumlupinar Univ, Fac Med, Dept Urol, TR-43100 Kutahya, Turkey
关键词
electrical stimulation; urinary incontinence; urodynamics; neuromodulation; Parkinson's disease; PTNS; CORD-INJURY PATIENTS; ELECTRICAL-STIMULATION; VOIDING DYSFUNCTION; URINARY SYMPTOMS; BLADDER; NEUROMODULATION; VARIABILITY; INSTABILITY; INHIBITION; CYSTOMETRY;
D O I
10.1002/nau.20593
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Aims: Lower urinary tract dysfunction is often occurs in patients with Parkinson's disease (PD), that is primarily induced by neurogenic detrusor overactivity (NDO) and negatively effect the quality of the patient's life. The aim of this study is to evaluate the acute effects of posterior tibial nerve stimulation (PTNS) on the urodynamic findings in the PD patients with NDO. Methods: Thirty-two patients with PD (19 [59.3%] men and 13 [40.6%] women) with NDO were included in the study. Mean age of the patients was 64.2 +/- 8.7 years (range 44-78). Urodynamic studies before and during PTNS were performed. Electrical stimulation was applied unilaterally from the medial malleolus and posterior to the edge of the tibia by using charge-compensated 200 mu sec pulses with a pulse rate of 20 Hz. Mean first involuntary detrusor (1st IDCV) contractions and means maximum cystometric capacity (MCC) before and during PTNS was compared. Results: Mean 1st 1DCV on standard cystometry was 145.2 +/- 41.1 (55-265) ml, while it was 244.7 +/- 51.7 (145-390) ml during PTNS. MCC on standard cystometry was 204.8 +/- 40.5 (115-320) ml, while it was 301.2 +/- 51.5 (230-395) ml during stimulation. Mean 1st IDC and mean MCC were significantly improved during PTNS. Conclusions: These results have demonstrated the objective acute effect of PTNS on urodynamic parameters. PTNS is acutely effective to suppress detrusor overactivity in PD patients. Neurourol. Urodynam. 28:62-67, 2009. (C) 2008 Wiley-Liss, Inc.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 50 条
  • [21] The efficacy of intra-vesical Botox in patients with Parkinson's disease and neurogenic detrusor overactivity
    Chan, L.
    Arianayagam, R.
    Collins, R.
    Tse, V.
    BJU INTERNATIONAL, 2018, 121 : 8 - 8
  • [22] Urodynamic monitoring during percutaneous sacral nerve neurostimulation in patients with neurogenic detrusor hyperreflexia
    Chartier-Kastler, EJ
    Denys, P
    Chancellor, MB
    Haertig, A
    Bussel, B
    Richard, F
    NEUROUROLOGY AND URODYNAMICS, 2001, 20 (01) : 61 - 71
  • [23] PERCUTANEOUS AND TRANSCUTANEOUS TIBIAL NERVE STIMULATION IN TREATMENT OF PATIENTS WITH OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY, REFRACTORY TO ANTIMUSCARINICS.
    Krivoborodov, G.
    Tur, E.
    Efremov, N.
    Khachaturova, N.
    NEUROUROLOGY AND URODYNAMICS, 2017, 36 : S457 - S458
  • [24] Comparison of the efficacy and safety of sacral root magnetic stimulation with transcutaneous posterior tibial nerve stimulation in the treatment of neurogenic detrusor overactivity: an exploratory randomized controlled trial
    Zhao, Yifan
    Wang, Daming
    Zou, Liliang
    Mao, Lin
    Yu, Ying
    Zhang, Tianfang
    Bai, Bing
    Chen, Zuobing
    TRANSLATIONAL ANDROLOGY AND UROLOGY, 2022, 11 (06) : 821 - 831
  • [25] Urodynamic effect of acute transcutaneous posterior tibial nerve stimulation in overactive bladder
    Amarenco, G
    Ismael, SS
    Even-Schneider, A
    Raibaut, P
    Demaille-Wlodyka, S
    Parratte, B
    Kerdraon, J
    JOURNAL OF UROLOGY, 2003, 169 (06): : 2210 - 2215
  • [26] The Clinical and Urodynamic Results of a 3-Month Percutaneous Posterior Tibial Nerve Stimulation Treatment in Patients With Multiple Sclerosis-Related Neurogenic Bladder Dysfunction
    Kabay, Sahin
    Kabay, Sibel Canbaz
    Yucel, Mehmet
    Ozden, Hilmi
    Yilmaz, Zahide
    Aras, Ozgen
    Aras, Bahar
    NEUROUROLOGY AND URODYNAMICS, 2009, 28 (08) : 964 - 968
  • [27] Urodynamic monitoring during percutaneous sacral nerve neurostimulation in patients with neurogenic detrusor hyperreflexia - Editorial comment
    Hohenfellner, M
    NEUROUROLOGY AND URODYNAMICS, 2001, 20 (01) : 71 - 71
  • [28] Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience
    Saito, M
    Watanabe, T
    Tabuchi, F
    Otsubo, K
    Satoh, K
    Miyagawa, I
    INTERNATIONAL JOURNAL OF UROLOGY, 2004, 11 (08) : 592 - 596
  • [29] Correlation between the overactive bladder questionnaire (OAB-Q) and urodynamic data of Parkinson's disease patients affected by neurogenic detrusor overactivity during antimuscarinic treatment
    Palleschi, G.
    Pastore, A.
    Stocchi, F.
    Inghilleri, M.
    Bova, G.
    Carbone, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 273 - 273
  • [30] Neuromodulation: urodynamic effects of sacral (S3) spinal nerve stimulation in patients with detrusor instability or detrusor hyperflexia
    Bosch, JLHR
    Groen, J
    BEHAVIOURAL BRAIN RESEARCH, 1998, 92 (02) : 141 - 150